NYSE (USA) TSX (CANADA)

Directory of Stock Market Company

This site is a directory of Stock Market Company in USA and Canada. Each company page contains a description, stock quote, news and much more. You have also access to the best stock market game on the web.

Search into NYSE and TSX
by quote, company name or key word

facebooktwitterlinkedin
Mail

APRI - Apricus Biosciences Inc

Apricus Biosciences, Inc., formerly NexMed, Inc., incorporated in 1987, is a pharmaceutical research and development company focused on the design and development of products and technologies in multiple therapeutic areas, including oncology, sexual dysfunction, autoimmune diseases and pain/inflammation. Its drug delivery technology is called NexACT. The Company has two ope","NYSE, Nasdaq, S&P, trading, US market, Asian market, Dow Jones, FTSE, DJIA, DAX, stocks, bonds, shares","Connect to the most current information on stocks and bonds on Reuters.com. What you need to know now about NYSE, Dow Jones, S&P, and Nasdaq at Reuters.com"

# APRIhart

Apricus Biosciences Inc News


Apricus Biosciences Granted Regulatory Guidance With FDA for MycoVa(TM) for ...
MarketWatch (press release) - 6 hours ago
SAN DIEGO, May 22, 2012 (GlobeNewswire via COMTEX) -- Apricus Biosciences, Inc. ("Apricus Bio" or the "Company") (NASDAQ:APRI) ( http://www.
US FDA Grants Apricus Biosciences' Request For Type C Guidance For MycoVa - RTT News

Apricus Biosciences Granted Regulatory Meeting With FDA For Femprox
RTT News - May 21, 2012
(RTTNews) - Apricus Biosciences Inc. (APRI: News ) announced that US Food and Drug Administration has granted the Company's request for a Type C meeting to obtain regulatory guidance from the agency for Femprox, the Company's topical alprostadil cream ...
Apricus Biosciences Granted Regulatory Meeting With FDA for Femprox(R) for the ... - MarketWatch (press release)

Apricus Biosciences to Present at the 11th Annual JMP Securities Research ...
MarketWatch (press release) - May 14, 2012
SAN DIEGO, May 14, 2012 (GlobeNewswire via COMTEX) -- Apricus Biosciences, Inc. ("Apricus Bio") (NASDAQ:APRI) announced today that Edward Cox, Vice President Corporate Development and Investor Relations, will present at the 11th Annual JMP Securities ...

Health Canada Grants Apricus Pre-NDS Meeting for MycoVa
RTT News - May 11, 2012
(RTTNews) - Apricus Biosciences Inc. (APRI: News ) announced that Health Canada has granted the Company's request for a Pre-New Drug Submission or Pre-NDS meeting to obtain regulatory guidance from the agency for MycoVa, the company's topical treatment ...

Apricus Biosciences Announces First Quarter 2012 Financial Results Conference ...
MarketWatch (press release) - May 8, 2012
SAN DIEGO, May 8, 2012 (GlobeNewswire via COMTEX) -- Apricus Biosciences, Inc. ("Apricus Bio") (UTD:APRI) announced today that management will hold a conference call to discuss its first quarter 2012 financial results and ongoing corporate activities ...

Health Canada Grants Apricus Biosciences Pre-NDS Meeting for Femprox for ...
NASDAQ - May 7, 2012
SAN DIEGO, May 7, 2012 (GLOBE NEWSWIRE) -- Apricus Biosciences, Inc. ("Apricus Bio" or the "Company") (Nasdaq:APRI) (http://www.

Health Canada Grants Apricus Biosciences Pre-NDS Meeting for Femprox for ...
MarketWatch (press release) - May 7, 2012
SAN DIEGO, May 7, 2012 (GlobeNewswire via COMTEX) -- Apricus Biosciences, Inc. ("Apricus Bio" or the "Company") (UTD:APRI) ( http://www.

Apricus Biosciences Announces Poster Presentation of Femprox(R) Phase III ...
NASDAQ - May 4, 2012
SAN DIEGO, May 4, 2012 (GLOBE NEWSWIRE) -- Apricus Biosciences, Inc. ("Apricus Bio" or the "Company") (Nasdaq:APRI) (http://www.

Apricus Biosciences Announces Poster Presentation of Femprox(R) Phase III ...
MarketWatch (press release) - May 4, 2012
SAN DIEGO, May 4, 2012 (GlobeNewswire via COMTEX) -- Apricus Biosciences, Inc. ("Apricus Bio" or the "Company") (UTD:APRI) ( http://www.

Interview With The President And CEO: Apricus Biosciences, Inc. (APRI ...
The Wall Street Transcript - May 1, 2012
May 1, 2012 - The Wall Street Transcript has just published Biotechnology and Pharmaceuticals Report offering a timely review of the sector.

NYSE Media Coverage Selection of the best articles found in your favorit medias

Next Company >>